Rex Fang & Innovation Equity Premium Income ETF vs FMC Corp — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $41.8, while FMC Corp trades at $10.48 (market cap $1.30B). The key difference: FMC Corp pays a 3.07% dividend while Rex Fang & Innovation Equity Premium Income ETF pays none, and Rex Fang & Innovation Equity Premium Income ETF is trading nearer its 52-week high, FMC Corp nearer its low. Which is the better fit depends on your goals.
| FEPI | FMC | |
|---|---|---|
Sector | Income / Options Overlay | Basic Materials |
52-Week High | $49.54 | $40.69 |
52-Week Low | $37.98 | $10.01 |
Market Cap | — | $1.30B |
Enterprise Value | — | $5.11B |
Dividend Yield | — | 3.07% |
Signals from Pluang's Aura AI — not financial advice
FEPI trades at $41.88 with minimal daily movement, showing technical bullish signals from moving averages while oscillators remain neutral. The ETF generates substantial income through weekly dividend distributions averaging $0.20-0.21 per share, funded by its covered call strategy on concentrated AI and tech holdings. Recent news highlights the fund's transition to weekly distributions and ongoing discussions about its aggressive income approach.
The high-yield strategy presents income opportunities but carries significant risk from NAV erosion during market downturns. While technical indicators suggest near-term strength, fundamental concerns about the sustainability of 25% yields and concentrated exposure to volatile tech names warrant cautious positioning. The covered call approach limits upside potential while providing consistent cash flow.
FMC Corporation (FMC) trades at $10.24, down 2.1% today, reflecting ongoing investor concerns despite recent earnings beats. The stock shows a bearish technical signal with key support at $10 and resistance at $11. Fundamentally, the company faces significant challenges with a net income margin of -84.83% and negative ROE of -91.47% for 2025, though valuation ratios like P/S of 0.4 and P/B of 0.8 appear attractive. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide technology.
The outlook remains cautious due to persistent profitability issues and revenue declines, with 2025 revenue dropping to $3.47B from $4.2B in 2024. While analyst consensus is mixed with a $11.60 price target suggesting modest upside, high debt levels and competitive pressures pose substantial risks. The company's focus on debt reduction through asset sales and external investments provides some stability, but turnaround execution is critical for sustained recovery.
Trailing returns across standard periods
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →